Dr Reddys Laboratories announces launch of generic Azacitidine for Injection

In Canada
Dr Reddys Laboratories announced that generic Azacitidine for Injection 100mg/vial, bioequivalent generic version of VIDAZA, is approved by Health Canada. VIDAZA is trademark of Celgene.Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 02 2017 | 7:47 PM IST
